U.S. FDA Approves Expanded Label for Astellas’ IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
HO
Press Releases
Astellas Pharma Inc.  
February 12, 2025

U.S. FDA Approves Expanded Label for Astellas’ IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy

IZERVAY dosing approved beyond 12 months

avatar profile Olean Times Herald

Olean Times Herald


Local & Social